{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-043324","form_type":"8-K","ticker":"MRAI","cik":"0001844392","company_name":"Marpai, Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.101883+00:00","generated_at":"2026-05-21T10:03:10.637890+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Marpai Q1 2025 revenue $5.4M down 27% YoY; operating loss narrows 45% to $2.3M","bullets":["Net revenue $5.4M, down $2.0M (27%) vs Q1 2024; operating expenses cut 33% to $7.7M.","Operating loss improved 45% to $2.3M; net loss $3.1M improved 29% vs prior year.","EPS of ($0.21), improvement of $0.25 per share year over year.","Unrestricted cash $0.7M at quarter end; CEO targets profitability and positive cash flow by end of 2025.","Key initiatives: launch of Healthcare Management tool with Empara, MarpaiRx advancements, new COO Dallas Scrip onboarded."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-043324","json":"https://secwatch.observer/filing/0001213900-25-043324.json","markdown":"https://secwatch.observer/filing/0001213900-25-043324.md","text":"https://secwatch.observer/filing/0001213900-25-043324.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844392/000121390025043324/0001213900-25-043324-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844392/000121390025043324/ea0242151-8k_marpai.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T10:03:10.637890+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}